ProCE Banner Activity

FAQs: Preventing COVID-19 in the Setting of Obesity or Metabolic Syndrome

Clinical Thought

Read these experts’ take on the current and potential novel treatment options, including antivirals and the keto diet, for severe COVID-19 infection or long COVID in patients with metabolic syndrome or obesity.

Released: August 22, 2023

Share

Faculty

Rasika Karnik

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Donna H Ryan

Donna H Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
LSU
Baton Rouge, Louisiana

Renslow Sherer

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC. in partnership with Practicing Clinicians Exchange

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Select the most appropriate prevention and treatment strategies for COVID-19 in ambulatory patients with obesity and/or metabolic syndrome

Disclosure

Primary Author

Rasika Karnik, MS, MD

Assistant Professor
Division of Primary Care, Department of Internal Medicine
University of Chicago
Medical Director
Post-Covid Recovery Clinic
Chicago, Illinois

Rasika Karnik, MS, MD: consultant/advisor/speaker: Gilead Sciences.

Donna H Ryan, MD

Professor Emerita
Pennington Biomedical Research Center
LSU
Baton Rouge, Louisiana

Donna Ryan, MD: advisor: Altimmune, Amgen, Biohaven, Boeringer Ingelheim, Calibrate, Carmot, Epitomee, Gila Therapeutics, Lilly, Novo Nordisk, Scientific Intake, Structure Tx, Xeno, YSOPIA, Zealand; speaker: IFA Celtic, Novo Nordisk, Lilly; individual publicly traded stock/stock options: Epitomee, Calibrate, Ro, Scientific Intake, Xeno; clinical trial: Novo Nordisk; data safety monitoring board: IQVIA (Rhythm), Lilly.

Renslow Sherer, MD

Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois

Renslow Sherer, MD: researcher: Gilead.